Guidance: Revenue expected in the range of $160 million to $165 million for FY2026, with adjusted EBITDA margin targeted at 8 ...

The rollout marks one of the largest live-event deployments of mobile solar today and offers a high-profile test for organic, ...

Telix, a commercial-stage biopharmaceutical company, announces that its prostate cancer PET imaging agent, Illuccix (kit for the preparation of gallium-68 gozetotide injection), has been granted ...

Taylor Swift announced she now owns all the music she ever made. This reported US$360 million acquisition includes all the ...

China NMPA accepts Hutchmed & Innovent’s NDA for fruquintinib in combo with sintilimab to treat advanced renal cell carcinoma: Hong Kong, Shanghai Friday, June 6, 2025, 09:00 Hr ...